https://pharmadog.xyz/news/468651 pharmadog en 2026-09-28T17:55:51.000Z Trump administration seeks Supreme Court stay on gender-affirming care restrictions in federal prisons https://pharmadog.xyz/news/468607 pharmadog en 2026-09-28T17:41:21.000Z White House seeks data on U.S. manufacturing of 86 essential medicines https://pharmadog.xyz/news/468503 pharmadog en 2026-09-28T16:11:00.000Z Kodiak Sciences' Phase 3 eye drug data beats Regeneron’s Eylea, shares double https://pharmadog.xyz/news/468504 pharmadog en 2026-09-28T15:52:00.000Z Adicet's off-the-shelf CAR-T shows 50% kidney response in early lupus trial https://pharmadog.xyz/news/468271 pharmadog en 2026-09-28T15:45:19.000Z Nonprofits launch ultra-rare immune disease gene therapy Waskyra at $3.25 million price https://pharmadog.xyz/news/468272 pharmadog en 2026-09-28T15:22:04.000Z Scynexis secures $200M+ BARDA contract for investigational antifungal SCY-247 https://pharmadog.xyz/news/468273 pharmadog en 2026-09-28T15:19:38.000Z Kodiak Sciences reports Phase 3 success for Zenkuda, matching Eylea in wet AMD https://pharmadog.xyz/news/468295 pharmadog en 2026-09-28T15:11:01.000Z Kodiak Sciences' zenkuda and tabirafusp-ted match Eylea in Phase 3, sending stock up 166% https://pharmadog.xyz/news/468147 pharmadog en 2026-09-28T14:55:21.000Z Rising health insurance premiums and a private equity hospital chain's shift to nonprofit highlight bleak outlook for US healthcare costs https://pharmadog.xyz/news/468103 pharmadog en 2026-09-28T14:06:16.000Z Roche halts development of muscle-preserving obesity drug and returns program to Chugai https://pharmadog.xyz/news/468104 pharmadog en 2026-09-28T14:00:16.000Z Merck licenses KRAS G12D inhibitor from Tao Hu for $400 million upfront https://pharmadog.xyz/news/467959 pharmadog en 2026-09-28T13:57:13.000Z Mirum receives FDA approval for Atebrioz, third therapy for ultra-rare bone disease FOP https://pharmadog.xyz/news/467960 pharmadog en 2026-09-28T13:50:27.000Z Merck signs up to $2.13 billion deal with SciBrunch for preclinical KRAS inhibitor SPR2015 https://pharmadog.xyz/news/467979 pharmadog en 2026-09-28T13:40:32.000Z AbbVie’s once-daily Parkinson’s pill receives FDA approval https://pharmadog.xyz/news/467961 pharmadog en 2026-09-28T13:33:58.000Z BioSpace report examines factors driving employee engagement in life sciences firms https://pharmadog.xyz/news/467980 pharmadog en 2026-09-28T13:06:52.000Z GLP-1 drugs shift from obesity treatment to lifestyle products, prompting setbacks for Merck and Daiichi https://pharmadog.xyz/news/467831 pharmadog en 2026-09-28T12:52:00.000Z Merck, Daiichi end plans to seek speedy approval of lung cancer ADC https://pharmadog.xyz/news/467811 pharmadog en 2026-09-28T12:22:37.000Z Trump administration pulls nearly $1 billion from HHS programs for immigrants and diversity https://pharmadog.xyz/news/467791 pharmadog en 2026-09-28T12:16:02.000Z AbbVie receives FDA approval for Parkinson’s drug Juvmo, a Cerevel acquisition asset https://pharmadog.xyz/news/467515 pharmadog en 2026-09-28T11:15:56.000Z Merck and Daiichi Sankyo pull accelerated approval request for lung cancer ADC https://pharmadog.xyz/news/467491 pharmadog en 2026-09-28T11:13:26.000Z Merck and Daiichi withdraw FDA accelerated approval filing for B7-H3 ADC in small cell lung cancer https://pharmadog.xyz/news/468246 pharmadog en 2026-09-28T11:05:00.000Z Roche halts obesity antibody emugrobart after negative phase 2 interim readout https://pharmadog.xyz/news/467910 pharmadog en 2026-09-28T09:37:00.000Z Mirum's Phase 3 Trial Shows Brelovitug Achieves Primary Endpoint in Hepatitis D Study https://pharmadog.xyz/news/467911 pharmadog en 2026-09-28T09:30:00.000Z Scynexis secures $214 million BARDA contract to advance oral and IV antifungal SCY-247 https://pharmadog.xyz/news/467220 pharmadog en 2026-09-28T09:00:00.000Z Operational talent, not just science, will drive next biopharma breakthroughs https://pharmadog.xyz/news/467219 pharmadog en 2026-09-28T09:00:00.000Z Azurity urges simpler medicines for children to reduce daily burdens on families https://pharmadog.xyz/news/467912 pharmadog en 2026-09-28T09:00:00.000Z Tolerance Bio signs up to $560M deal for anti-IL-33 drug from Tanabe https://pharmadog.xyz/news/468418 pharmadog en 2026-09-28T08:51:00.000Z Precision Neuroscience raises $250M in Series D to expand brain-computer interface program https://pharmadog.xyz/news/467913 pharmadog en 2026-09-28T08:37:00.000Z Kodiak Sciences' eye disease drug matches Eylea in Phase 3, sending stock soaring https://pharmadog.xyz/news/467031 pharmadog en 2026-09-28T08:30:00.000Z Novo Nordisk rebrands GLP-1 therapy Wegovy as weight-loss product, positioning it as lifestyle drug https://pharmadog.xyz/news/467032 pharmadog en 2026-09-28T08:30:00.000Z AI tools that aid vaccine design could also accelerate creation of bioweapons, warns former White House Covid adviser https://pharmadog.xyz/news/467033 pharmadog en 2026-09-28T08:30:00.000Z Researchers identify previously unseen structure in the human heart https://pharmadog.xyz/news/467916 pharmadog en 2026-09-28T08:11:00.000Z Merck signs $400 million deal with China’s SciBrunch for KRAS G12D preclinical candidate https://pharmadog.xyz/news/467742 pharmadog en 2026-09-28T08:06:00.000Z Sofinnova Partners raises €82 million to expand medtech creation strategy in Europe and U.S. https://pharmadog.xyz/news/466507 pharmadog en 2026-09-28T05:01:00.000Z Regenerative medicine requires diagnostics and product characterization beyond stem cell basics https://pharmadog.xyz/news/466231 pharmadog en 2026-09-28T04:02:00.000Z Ultragenyx gains FDA approval for Fayuvi, a Sanfilippo syndrome A therapy, easing impact of recent Angelman setback https://pharmadog.xyz/news/466232 pharmadog en 2026-09-28T04:01:00.000Z Biopharma chases new immunology targets as Humira and Dupixent set high bar https://pharmadog.xyz/news/466962 pharmadog en 2026-09-28T03:40:00.000Z Merck and Daiichi withdraw lung cancer ADC filing after FDA says data insufficient https://pharmadog.xyz/news/468513 pharmadog en 2026-09-28T00:00:00.000Z FDA CDER chief says expanding generic GLP-1 drugs is top priority to cut American costs https://pharmadog.xyz/news/455856 pharmadog en 2026-09-26T22:17:00.000Z Mezzetta voluntarily recalls 32-oz Golden Greek Peperoncini after pest contaminant found in jar